Skip to main
ARAY

Accuray (ARAY) Stock Forecast & Price Target

Accuray (ARAY) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Accuray is currently facing challenges due to geopolitical pressures and macroeconomic headwinds, which have led to lower orders and revenue. However, the company's transformation plan is underway, and management remains committed to achieving a high single-digit adjusted EBITDA margin and a double-digit margin in the long-term, presenting potential upside for investors. While the company's earnings and order volume have been impacted, they continue to innovate with their CyberKnife technology, providing precise and efficient treatment options for cancer patients.

Bears say

Accuray is currently facing several challenges that have led us to have a negative outlook on the stock. Firstly, the company's recent transformation plan has not yielded the expected results, with declining revenue and missed earnings expectations. Additionally, geopolitical uncertainty in the Middle East has affected the company's ability to make sales and fulfill orders, leading to a lack of visibility on a potential turnaround. In light of these factors, we have downgraded our rating from Buy to Neutral and removed our price target.

Accuray (ARAY) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Accuray and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Accuray (ARAY) Forecast

Analysts have given Accuray (ARAY) a Buy based on their latest research and market trends.

According to 2 analysts, Accuray (ARAY) has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $1.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $1.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Accuray (ARAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.